MicroRNA152-3p Protects Against Ischemia/Reperfusion-Induced Bbb Destruction Possibly Targeting the MAP3K2/JNK/c-Jun

Fei Li1, Fangfang Zhou2, Binbin Yang3

  • 1Department of Neurology, Changzheng Hospital, Naval Medical University, Shanghai, China.

Neurochemical Research
|November 29, 2022
PubMed

Insights

MicroRNA-152-3p overexpression protects the brain after stroke by reducing neurological deficits and maintaining blood-brain barrier integrity. This microRNA also prevents endothelial cell death and hyperpermeability in stroke models.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Stroke, particularly ischemic stroke caused by middle cerebral artery occlusion (MCAO), leads to significant neurological deficits.
  • Maintaining blood-brain barrier (BBB) integrity is crucial for mitigating ischemic brain injury.
  • MicroRNAs (miRNAs) play vital roles in regulating cellular responses to ischemic conditions.

Purpose of the Study:

  • To investigate the role of miR-152-3p in protecting against ischemic stroke.
  • To elucidate the underlying molecular mechanisms of miR-152-3p's protective effects.

Main Methods:

  • Utilized a middle cerebral artery occlusion (MCAO) rat model to induce ischemic stroke.
  • Employed an in vitro oxygen-glucose deprivation/reperfusion (OGD/R) model using bEnd.3 cells.
  • Assessed neurological deficits, BBB integrity, and endothelial cell apoptosis.
  • Investigated the modulation of the MAP3K2/JNK/c-Jun signaling pathway.

Main Results:

  • Overexpression of miR-152-3p significantly ameliorated neurological deficits in MCAO rats.
  • miR-152-3p levels were decreased in bEnd.3 cells following OGD/R insult.
  • Overexpressing miR-152-3p protected bEnd.3 cells from OGD/R-induced microvascular hyperpermeability.
  • The protective effect involved negative modulation of the MAP3K2/JNK/c-Jun pathway, leading to reduced endothelial apoptosis.

Conclusions:

  • miR-152-3p acts as a protective factor against ischemic stroke.
  • Restoring miR-152-3p levels may be a therapeutic strategy for stroke.
  • The mechanism involves inhibiting endothelial apoptosis via the MAP3K2/JNK/c-Jun pathway.